Christopher Ogden - Net Worth and Insider Trading
Christopher Ogden Net Worth
The estimated net worth of Christopher Ogden is at least $108,077 dollars as of 2024-11-05. Christopher Ogden is the CFO of CytomX Therapeutics Inc and owns about 108,077 shares of CytomX Therapeutics Inc (CTMX) stock worth over $108,077. Details can be seen in Christopher Ogden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Ogden has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Ogden
Christopher Ogden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Ogden owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Christopher Ogden’s form 4 insider trades.
Insider Ownership Summary of Christopher Ogden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | SVP & Finance and Accounting |
Christopher Ogden Latest Holdings Summary
Christopher Ogden currently owns a total of 1 stock. Christopher Ogden owns 108,077 shares of CytomX Therapeutics Inc (CTMX) as of August 20, 2024, with a value of $108,077.
Latest Holdings of Christopher Ogden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | 108,077 | 1.00 | 108,077 |
Holding Weightings of Christopher Ogden
Christopher Ogden Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Ogden has made a total of 4 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 1,984 shares on August 20, 2024, which brought Christopher Ogden around $2,440.
Insider Trading History of Christopher Ogden
- 1
Christopher Ogden Trading Performance
Christopher Ogden Ownership Network
Ownership Network List of Christopher Ogden
Ownership Network Relation of Christopher Ogden
Christopher Ogden Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Christopher Ogden is the SVP & Finance and Accounting of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , Chief Financial Officer Jeffrey B Landau , and General Counsel Lloyd A Rowland .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Christopher Ogden made 3 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 6,945. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Christopher Ogden Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Ogden. You might contact Christopher Ogden via mailing address: C/o Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Suite 400, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
